Compare Cipta Sarana Medika Tbk. (DKHH) vs Lippo Karawaci Tbk. (LPKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Lippo Karawaci Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Lippo Karawaci Tbk. trades at Rp60 (market cap 4.25T, 112.03M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 26.9× Cipta Sarana Medika Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (112.03M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | LPKR | |
|---|---|---|
Market Cap | 158.12B | 4.25T |
Volume | 8.21M | 112.03M |
Lot | 82.15K | 1.12M |
Turnover | 515.2M | 6.81B |
Average Price | 62.72 | 60.76 |
Value | 515.2M | 6.81B |
Indicative Equilibrium Price | 63 | 60 |
Indicative Equilibrium Volume | 1.33K | 44.54K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Lippo Karawaci Tbk.
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →
